Trial intelligence / Profile preview

Benzydamine Spray vs Lozenges for Acute Sore Throat

NCT04941976Phase 4Completed

Sponsor
Angelini Pharma
Start
Aug 2020
Primary completion
Jun 2021
Modality
Orthosteric Ligands
Countries
3
01

Overview

Phase 4, randomised, open-label trial of benzydamine in acute pharyngitis (2 arms), sponsored by Angelini Pharma. Primary endpoint: Percentage of responders at 2 minutes. Started Aug 2020; status: completed.

02

Drugs

benzydamine
03

Conditions

acute pharyngitis

Beyond the preview

Go deeper on NCT04941976.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04941976.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call